R. Tanpure

发表

Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment

R. Mason, Maoping Li, M. L. Trawick, 2021, Cancers.

Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization.

R. Mason, D. Chaplin, T. E. Strecker, 2016, MedChemComm.

Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4.

Y. Sheng, J. Hua, K. Edvardsen, 2003, Bioorganic & medicinal chemistry letters.

Synthesis and Evaluation of Antimalarial Properties of Novel 4‐Aminoquinoline Hybrid Compounds

K. Andrews, G. Fisher, S. Poulsen, 2014, Chemical biology & drug design.

Asymmetric Total Synthesis of (-) Podophyllotoxin

S. Bhat, R. Tanpure, S. B. Hadimani, 1996 .

Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents.

E. Hamel, M. L. Trawick, R. Tanpure, 2009, Bioorganic & medicinal chemistry.

Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.

D. Chaplin, B. Siim, M. L. Trawick, 2010, Journal of natural products.

Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization.

R. Mason, D. Chaplin, E. Hamel, 2015, Bioorganic & medicinal chemistry.

Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site.

C. Supuran, T. Peat, D. Vullo, 2015, Journal of medicinal chemistry.

Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.

D. Chaplin, M. L. Trawick, R. Tanpure, 2013, Bioorganic & medicinal chemistry.

Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1.

D. Chaplin, E. Hamel, B. Siim, 2011, Journal of natural products.

An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable Cytotoxicity.

D. Chaplin, E. Hamel, M. L. Trawick, 2012, MedChemComm.

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment

R. Mason, H. Hammers, M. L. Trawick, 2022, Cancers.

Synthesis and Evaluation of Antimalarial Properties of Novel 4‐Aminoquinoline Hybrid Compounds

K. Andrews, G. Fisher, S. Poulsen, 2014, Chemical Biology and Drug Design.